[Syncitia inducing phenotype, zidovudine++ resistance and fast clinical progression in a child infected by HIV].
Mellado Peña
M J
MJ
Servicio de Pediatría, Instituto de Salud Carlos III, Majadahonda, Madrid.
Villota Arrieta
J
J
Bernal Zamora
A
A
Cilleruelo Ortega
M J
MJ
García López
M
M
Barreiro Casal
G
G
Pérez Jurado
M L
ML
Martín Fontelos
P
P
D000890:Anti-Infective Agents / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D002648:Child; D017809:Fatal Outcome; D006679:HIV Seropositivity / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D010641:Phenotype; D016720:Pneumocystis Infections / Q000188:drug therapy / Q000517:prevention & control; D014057:Tomography, X-Ray Computed; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D015215:Zidovudine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
Fenotipo inductor de sincitio, resistencia a zidovudina y rápida progresión clínica en un niño infectado por VIH.